Alpha blockers: an effective extension to your patients' risk reduction program.
This symposium discusses a rapidly changing philosophy in how to manage hypertension. Many committees in the United States and Canada over the years have tried to make the treatment of hypertension simple. And in their goal to do that, they have made it difficult and led many down a primrose path with somewhat narrow vision. One famous British physician in 1931 said, "the greatest danger to man with high blood pressure lies in its discovery since some fool is certain to try to reduce it." There is a lot of credence to that rule.
Houston
M C
MC
Department of Medicine, Vanderbilt University, St. Thomas Medical Group, Nashville, Tennessee 37205.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D003327:Coronary Disease / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008055:Lipids / Q000097:blood; D012307:Risk Factors
D000317:Adrenergic alpha-Antagonists; D008055:Lipids